Dosimetric comparison of VitalBeam(®) and Halcyon(TM) 2.0 for hypofractionated VMAT with simultaneous integrated boost treatment of early‐stage left‐sided breast cancer

PURPOSE: This study compared the quality of treatment plans for early‐stage, left‐sided breast cancer, as planned for and delivered by the Halcyon(TM) and VitalBeam(®). MATERIALS AND METHODS: Fifteen patients diagnosed with early‐stage left‐sided breast cancer, who had received VMAT with hypofractio...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Eunbin, Heo, Eun Jeong, Park, Chun Gun, Kim, Minseok, Kim, Kwang Hyeon, Shim, Jang Bo, Park, Young Je, Lee, Nam Kwon, Kim, Chul Yong, Lee, Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Radiation Oncology Physics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504599/
https://www.ncbi.nlm.nih.gov/pubmed/34554605
http://dx.doi.org/10.1002/acm2.13428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504599/
https://www.ncbi.nlm.nih.gov/pubmed/34554605
http://dx.doi.org/10.1002/acm2.13428

Ejemplares similares